Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A05933 | 33071981 | Front Endocrinol (Lausanne) | Carotid Extra-Media Thickness in Children: Relationships With Cardiometabolic Risk Factors and Endothelial Function. | 2020 | Details |
| A05941 | 33069882 | Clin Gastroenterol Hepatol | Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus. | 2020 | Details |
| A05950 | 33065985 | Nutrients | Genomics in Personalized Nutrition: Can You "Eat for Your Genes"? | 2020 | Details |
| A05953 | 33064150 | J Clin Endocrinol Metab | The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients. | 2021 | Details |
| A05990 | 33049948 | Metabolites | What's Past Is Prologue: History of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05993 | 33047893 | Liver Transpl | Outcomes of Liver Transplantation Among Older Recipients With Nonalcoholic Steatohepatitis in a Large Multicenter US Cohort: the Re-Evaluating Age Limits in Transplantation Consortium. | 2020 | Details |
| A06007 | 33038914 | Curr Pediatr Rev | Cardiovascular Risk in Children with Nonalcoholic Fatty Liver Disease (NAFLD). | 2020 | Details |
| A06021 | 33037056 | Gut | Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort. | 2020 | Details |
| A06036 | 33032515 | Curr Med Imaging | Evaluation and Comparative Correlation of Abdominal Fat Related Parameters in Obese and Non-obese Groups Using Computed Tomography. | 2021 | Details |
| A06044 | 33030804 | J Diabetes Investig | Association of the Non-Alcoholic Fatty Liver Disease Fibrosis Score with subclinical myocardial remodeling in patients with type 2 diabetes: A cross-sectional study in China. | 2021 | Details |
| A06053 | 33027655 | Cell Rep | The Lipid Handling Capacity of Subcutaneous Fat Is Programmed by mTORC2 during Development. | 2020 | Details |
| A06054 | 33027082 | Am J Gastroenterol | Effects of Statin Use on the Development and Progression of Nonalcoholic Fatty Liver Disease: A Nationwide Nested Case-Control Study. | 2021 | Details |
| A06059 | 33025153 | Abdom Radiol (NY) | Liver fat quantification: where do we stand? | 2020 | Details |
| A06060 | 33024915 | Hepatol Commun | Therapeutic Targeting of Myeloperoxidase Attenuates NASH in Mice. | 2020 | Details |
| A06073 | 33016540 | Aliment Pharmacol Ther | Patterns and predictors of mortality and disease progression among patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A06074 | 33015726 | Curr Diab Rep | Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06086 | 33011976 | Acta Psychiatr Scand | Non-alcoholic fatty liver disease in a sample of individuals with bipolar disorders: results from the FACE-BD cohort. | 2020 | Details |
| A06088 | 33011191 | Prog Lipid Res | The multi-faces of Angptl8 in health and disease: Novel functions beyond lipoprotein lipase modulation. | 2020 | Details |
| A06089 | 33010471 | Mol Metab | Dysregulated lipid metabolism links NAFLD to cardiovascular disease. | 2020 | Details |
| A06098 | 33007859 | Biology (Basel) | Cholesterol Homeostasis: An In Silico Investigation into How Aging Disrupts Its Key Hepatic Regulatory Mechanisms. | 2020 | Details |
| A06100 | 33007508 | Clin Gastroenterol Hepatol | Association Between Lipoprotein Particles and Atherosclerotic Events in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06113 | 33002003 | PLoS One | REV-ERB agonism improves liver pathology in a mouse model of NASH. | 2020 | Details |
| A06142 | 32991173 | J Med Chem | Discovery and Optimization of Non-bile Acid FXR Agonists as Preclinical Candidates for the Treatment of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A06145 | 32988952 | BMJ Open | Systematic review of the impact of non-alcoholic fatty liver disease on mortality and adverse clinical outcomes for individuals with chronic kidney disease. | 2020 | Details |
| A06147 | 32987188 | Mol Metab | Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease. | 2020 | Details |
| A06155 | 32984791 | JHEP Rep | Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents. | 2020 | Details |
| A06157 | 32982804 | Front Physiol | Newly Discovered Adipokines: Pathophysiological Link Between Obesity and Cardiometabolic Disorders. | 2020 | Details |
| A06158 | 32982631 | J Taibah Univ Med Sci | A preliminary report about the detection of ventricular repolarisation in patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A06159 | 32982495 | Hepat Med | Identifying High-Risk NASH Patients: What We Know so Far. | 2020 | Details |
| A06169 | 32980849 | Cerebrovasc Dis | Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic Attack. | 2020 | Details |
| A06171 | 32979393 | Toxicol Appl Pharmacol | Perfluorooctanesulfonic acid (PFOS) administration shifts the hepatic proteome and augments dietary outcomes related to hepatic steatosis in mice. | 2020 | Details |
| A06192 | 32975060 | Yonsei Med J | Association between Atrial Fibrillation and Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A06195 | 32973925 | Therap Adv Gastroenterol | The role of the gut microbiome and exercise in non-alcoholic fatty liver disease. | 2020 | Details |
| A06213 | 32965553 | Wien Klin Wochenschr | Association between psoriasis, psoriatic arthritis and gastrointestinal disease : An exploratory nationwide inpatient sample analysis. | 2020 | Details |
| A06215 | 32964327 | Int J Cardiovasc Imaging | Correlation between computed tomography adapted leaman score and computed tomography liver and spleen attenuation parameters for non-alcoholic fatty liver disease as well as respective inflammatory mediators. | 2020 | Details |
| A06216 | 32964202 | JHEP Rep | Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease. | 2020 | Details |
| A06217 | 32964201 | JHEP Rep | The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care. | 2020 | Details |
| A06228 | 32961610 | J Diabetes Investig | Prevalence of non-alcoholic fatty liver disease and factors associated with it in Indian women with a history of gestational diabetes mellitus. | 2020 | Details |
| A06233 | 32960625 | Nutr Hosp | [Effectiveness of hydroxycinamates and beta-glucans as dietary tools against obesity and its associated dysfunctions, and their application as nutraceuticals]. | 2020 | Details |
| A06264 | 32947869 | Biomolecules | Inflammation in Obesity-Related Complications in Children: The Protective Effect of Diet and Its Potential Role as a Therapeutic Agent. | 2020 | Details |
| A06274 | 32945071 | Diabetes Obes Metab | A look to the future in non-alcoholic fatty liver disease: Are glucagon-like peptide-1 analogues or sodium-glucose co-transporter-2 inhibitors the answer? | 2020 | Details |
| A06300 | 32936098 | J R Coll Physicians Edinb | Diagnosis and management of fatty liver. | 2020 | Details |
| A06306 | 32934047 | Clin Med (Lond) | Non-alcoholic fatty liver disease. | 2020 | Details |
| A06313 | 32932674 | Molecules | Brown Seaweeds for the Management of Metabolic Syndrome and Associated Diseases. | 2020 | Details |
| A06317 | 32931760 | Am J Med | The Impact of Nonalcoholic Fatty Liver Disease in Primary Care: A Population Health Perspective. | 2020 | Details |
| A06327 | 32927776 | Nutrients | New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress. | 2020 | Details |
| A06340 | 32923108 | Am J Cardiovasc Dis | Increased cardiovascular events and mortality in females with NAFLD: a meta-analysis. | 2020 | Details |
| A06360 | 32916379 | Nutrition | Pleiotropic ameliorative effects of ellagitannin geraniin against metabolic syndrome induced by high-fat diet in rats. | 2020 | Details |
| A06401 | 32892547 | Turk J Med Sci | Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study | 2021 | Details |
| A06430 | 32883049 | Cells | A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology. | 2020 | Details |
| A06458 | 32874784 | PeerJ | Gender-specific associations between apolipoprotein A1 and arterial stiffness in patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A06466 | 32869884 | J Food Biochem | Remedial role of exercise training to deep-fried oil-induced metabolic and histological changes in Wistar rats. | 2020 | Details |
| A06467 | 32868684 | Curr Opin Clin Nutr Metab Care | Dietary protein intake and obesity-associated cardiometabolic function. | 2020 | Details |
| A06488 | 32859329 | Clin Nutr ESPEN | The effects of Bacillus coagulans supplementation in patients with non-alcoholic fatty liver disease: A randomized, placebo-controlled, clinical trial. | 2020 | Details |
| A06498 | 32852705 | J Endocrinol Invest | Circulating dipeptidyl peptidase-4 is independently associated with the presence and severity of NAFLD/NASH in individuals with and without obesity and metabolic disease. | 2020 | Details |
| A06501 | 32850903 | Front Med (Lausanne) | Insights Into Extracellular Vesicles as Biomarker of NAFLD Pathogenesis. | 2020 | Details |
| A06503 | 32849935 | J Clin Med Res | Non-Alcoholic Fatty Liver Disease Modifies Serum Gamma-Glutamyl Transferase in Cigarette Smokers. | 2020 | Details |
| A06507 | 32849291 | Front Endocrinol (Lausanne) | Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLD. | 2020 | Details |
| A06514 | 32847841 | BMJ Open Diabetes Res Care | Serum levels of mac-2 binding protein are associated with diabetic microangiopathy and macroangiopathy in people with type 2 diabetes. | 2020 | Details |
| A06521 | 32841652 | J Allergy Clin Immunol | Regulating metabolic inflammation by nutritional modulation. | 2020 | Details |
| A06522 | 32841505 | Liver Int | Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative. | 2020 | Details |
| A06525 | 32841140 | Medicina (B Aires) | [Diagnosis and treatment of non-alcoholic fatty liver disease. Argentine Association for the Study of Liver Diseases, year 2019]. | 2020 | Details |
| A06536 | 32833552 | J Med Food | Green Tea Consumption May Be Associated with Cardiovascular Disease Risk and Nonalcoholic Fatty Liver Disease in Type 2 Diabetics: A Cross-Sectional Study in Southeast China. | 2020 | Details |
| A06543 | 32832402 | J Clin Transl Hepatol | NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States. | 2020 | Details |
| A06545 | 32831555 | J Family Community Med | Prevalence and risk factors for nonalcoholic fatty liver disease in obese children in rural Punjab, India. | 2020 | Details |
| A06548 | 32829997 | J Diabetes Complications | NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes. | 2020 | Details |
| A06564 | 32824337 | Int J Mol Sci | History of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06565 | 32824277 | Int J Mol Sci | Lactobacillus Strains Alleviated Hyperlipidemia and Liver Steatosis in Aging Rats via Activation of AMPK. | 2020 | Details |
| A06566 | 32824177 | Nutrients | Effects of Dietary Phytoestrogens on Hormones throughout a Human Lifespan: A Review. | 2020 | Details |
| A06580 | 32821336 | World J Hepatol | Non-alcoholic steatohepatitis and the risk of myocardial infarction: A population-based national study. | 2020 | Details |
| A06581 | 32821071 | World J Gastroenterol | Helicobacter pylori infection: Beyond gastric manifestations. | 2020 | Details |
| A06582 | 32821068 | World J Gastroenterol | Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge. | 2020 | Details |
| A06587 | 32819262 | Curr Drug Saf | Efficacy and Cardiovascular Safety of DPP-4 Inhibitors. | 2021 | Details |
| A06624 | 32803141 | Cardiovasc Endocrinol Metab | Nonalcoholic fatty liver disease: implications for endocrinologists and cardiologists. | 2020 | Details |
| A06626 | 32802809 | J Hepatocell Carcinoma | Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes. | 2020 | Details |
| A06631 | 32800834 | Life Sci | High fructose intake and the route towards cardiometabolic diseases. | 2020 | Details |
| A06633 | 32800550 | Biochem Biophys Res Commun | Metformin, resveratrol, and exendin-4 inhibit high phosphate-induced vascular calcification via AMPK-RANKL signaling. | 2020 | Details |
| A06646 | 32795560 | Metabolism | Perturbation of the circadian clock and pathogenesis of NAFLD. | 2020 | Details |
| A06647 | 32795504 | Ageing Res Rev | Structure-functional implications of longevity protein p66Shc in health and disease. | 2020 | Details |
| A06667 | 32788075 | Surg Obes Relat Dis | Prevalence of NASH/NAFLD in people with obesity who are currently classified as metabolically healthy. | 2020 | Details |
| A06678 | 32783310 | Int J Exp Pathol | A "Western Diet" promotes symptoms of hepatic steatosis in spontaneously hypertensive rats. | 2020 | Details |
| A06687 | 32780624 | Metab Syndr Relat Disord | Lumican in Obese Patients with Nonalcoholic Fatty Liver Disease With or Without Prediabetes. | 2020 | Details |
| A06690 | 32779505 | J Am Heart Assoc | Effects of Epeleuton, a Novel Synthetic Second-Generation n-3 Fatty Acid, on Non-Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers. | 2020 | Details |
| A06694 | 32777482 | Biochim Biophys Acta Mol Cell Biol Lipids | Angiopoietin-like protein 3, an emerging cardiometabolic therapy target with systemic and cell-autonomous functions. | 2020 | Details |
| A06695 | 32777481 | Biochim Biophys Acta Mol Cell Biol Lipids | Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis. | 2020 | Details |
| A06710 | 32773176 | HPB (Oxford) | Cholecystectomy as a risk factor for non-alcoholic fatty liver disease development. | 2020 | Details |
| A06716 | 32771802 | Atherosclerosis | Serum lipoprotein(a) levels and insulin resistance have opposite effects on fatty liver disease. | 2020 | Details |
| A06731 | 32766474 | Hepatol Commun | Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities. | 2020 | Details |
| A06740 | 32764281 | Nutrients | The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases. | 2020 | Details |
| A06772 | 32752277 | Int J Mol Sci | Iron Metabolism in Obesity and Metabolic Syndrome. | 2020 | Details |
| A06777 | 32751658 | Cells | The Inflammasome in Chronic Complications of Diabetes and Related Metabolic Disorders. | 2020 | Details |
| A06782 | 32748075 | J Med Ultrason (2001) | Advances in ultrasound elastography for nonalcoholic fatty liver disease. | 2020 | Details |
| A06786 | 32746645 | Expert Rev Gastroenterol Hepatol | Clinical heterogeneity in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma. | 2020 | Details |
| A06794 | 32742574 | World J Hepatol | Non-alcoholic fatty liver disease is not independent risk factor for cardiovascular disease event: A cohort study. | 2020 | Details |
| A06807 | 32738385 | Alcohol | Moderate alcohol consumption is not associated with subclinical cardiovascular damage but with hepatic fibrosis in non-alcoholic fatty liver disease. | 2020 | Details |
| A06815 | 32736956 | Nutr Metab Cardiovasc Dis | Elevated blood pressure, cardiometabolic risk and target organ damage in youth with overweight and obesity. | 2020 | Details |
| A06819 | 32735532 | Endocr Metab Immune Disord Drug Targets | Ferroptotic Cell Death: New Regulatory Mechanisms for Metabolic Diseases. | 2021 | Details |
| A06838 | 32728634 | Clin Exp Hepatol | Left ventricular diastolic dysfunction in liver transplantation: a stronger association with non-alcoholic steatohepatitis. | 2020 | Details |
| A06849 | 32724678 | Int J Hepatol | Endothelial Dysfunction, a Marker of Atherosclerosis, Is Independent of Metabolic Syndrome in NAFLD Patients. | 2020 | Details |
| A06856 | 32720602 | Curr Vasc Pharmacol | Have We Learnt all from IMPROVE-IT? Part I. Core Results and Subanalyses on the Effects of Ezetimibe Added to Statin Therapy Related to Age, Gender and Selected Chronic Diseases (Kidney Disease, Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease). | 2021 | Details |